Michael Thomas
Impact in
- Cancer Research top 0.2%
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Pulmonary and Respiratory Medicine top 0.1%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 150
- Lung Cancer Diagnosis and Treatment 58
- Oncology 150
- Lung Cancer Research Studies 64
- Colorectal Cancer Treatments and Studies 27
- Cancer Immunotherapy and Biomarkers 27
- Cancer survivorship and care 17
- Co-authors
- Wolfgang E. Berdel (16 shared papers)Thomas Muley (62 shared papers)Hubert Serve (6 shared papers)Carsten Müller‐Tidow (6 shared papers)Sven Diederichs (5 shared papers)Paul M. Schneider (4 shared papers)Burkhard Brandt (6 shared papers)Ralf Metzger (3 shared papers)
- Journals
- Journal of Clinical Oncology (41 papers)Lung Cancer (30 papers)Annals of Oncology (23 papers)Journal of Thoracic Oncology (16 papers)Cancers (11 papers)
- Partner nations
- GermanyUnited StatesSpain
In The Last Decade
Michael Thomas
344 papers receiving 12.6k citations
Michael Thomas's Hit Papers
Peers
Comparison fields: 5 of 157
- Cancer Research 3.0k
- Pulmonary and Respiratory Medicine 5.3k
- Oncology 4.1k
- Molecular Biology 3.4k
- Radiology, Nuclear Medicine and Imaging 623
Countries citing papers authored by Michael Thomas
This map shows the geographic impact of Michael Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Thomas more than expected).
Fields of papers citing papers by Michael Thomas
This network shows the impact of papers produced by Michael Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Thomas. The network helps show where Michael Thomas may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 363 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer Hit paper breakdown → | 2003 | 1858 |
| 2 | The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival Hit paper breakdown → | 2012 | 547 |
| 3 | Early palliative care for adults with advanced cancer Hit paper breakdown → | 2017 | 489 |
| 4 | Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial Hit paper breakdown → | 2012 | 450 |
| 5 | PARAMOUNT: Final Overall Survival Results of the Phase III Study of Maintenance Pemetrexed Versus Placebo Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer Hit paper breakdown → | 2013 | 440 |
| 6 | 2002 | 400 | |
| 7 | 2010 | 365 | |
| 8 | 2015 | 319 | |
| 9 | 2011 | 243 | |
| 10 | 2008 | 230 | |
| 11 | 2010 | 228 | |
| 12 | 1998 | 224 | |
| 13 | 2012 | 173 | |
| 14 | 2004 | 168 | |
| 15 | 2015 | 146 | |
| 16 | 2018 | 139 | |
| 17 | 1997 | 134 | |
| 18 | 2004 | 133 | |
| 19 | 2001 | 132 | |
| 20 | 2018 | 118 |
About Michael Thomas
Michael Thomas is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Public Health, Environmental and Occupational Health, having authored 363 papers that have together received 12.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (150 papers), Lung Cancer Research Studies (64 papers), Lung Cancer Diagnosis and Treatment (58 papers), Cancer Genomics and Diagnostics (44 papers), Colorectal Cancer Treatments and Studies (27 papers), Cancer Immunotherapy and Biomarkers (27 papers), Cancer survivorship and care (17 papers) and Palliative Care and End-of-Life Issues (17 papers). The work is most often cited by research in Cancer Research (3.0k citations), Pulmonary and Respiratory Medicine (5.3k citations), Oncology (4.1k citations), Molecular Biology (3.4k citations) and Radiology, Nuclear Medicine and Imaging (623 citations). Michael Thomas has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Wolfgang E. Berdel, Thomas Muley, Hubert Serve, Carsten Müller‐Tidow, Sven Diederichs, Paul M. Schneider, Burkhard Brandt, Ralf Metzger, Etmar Bulk and Michael Meister. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, Annals of Oncology, Journal of Thoracic Oncology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.